This monograph investigates the pharmacological management and underlying neurochemical mechanisms of affective disorders within a clinical framework. Edited by A. Coppen and E.S. Paykel, the text synthesizes research from the British Association for Psychopharmacology to provide a comprehensive overview of treatment efficacy. It evaluates the intersection of biological psychiatry and therapeutic intervention, focusing on the stabilization of mood through chemical agents.

Experts recognize this monograph as a foundational text for understanding the clinical standards of psychopharmacology during its period of publication. Readers frequently note the academic density of the prose, which is intended for medical professionals and researchers in the field of psychiatry.